文献速递外周动脉疾病

术前糖化血红蛋白水平与下肢旁路术后不良肢体事件风险增加相关

Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2019-03-07

基于血管质量倡议(VQI)注册数据的回顾性研究,纳入7727例接受腹股沟下下肢旁路术的糖尿病患者,按术前HbA1c分层。多因素分析显示,HbA1c≥8%者较>6%至≤7%者院内不良肢体事件风险增加(OR 1.37,95%CI 1.01-1.86),但心血管事件和死亡风险无显著增加;分层分析中该关联仅见于无严重肢体缺血患者(OR 1.82,95%CI 1.05-3.16)。

要点

  • 术前HbA1c≥8%与腹股沟下旁路术后院内不良肢体事件风险增加独立相关。
  • 高HbA1c未显著增加心血管事件(OR 1.07)或死亡(OR 1.57)风险。
  • 不良肢体事件关联仅见于无严重肢体缺血患者,需关注该亚组血糖优化。

核心结论

  • 糖尿病患者腹股沟下下肢旁路术前血糖控制不佳(HbA1c≥8%)与院内不良肢体事件风险增加相关,尤其在无严重肢体缺血者中。

研究设计与样本

  • 回顾性队列研究,分析血管质量倡议(VQI)注册数据库2012年1月至2017年2月所有腹股沟下下肢旁路术。
  • 纳入 demographic 和临床数据完整且记录术前HbA1c的糖尿病患者共7727例。
  • 按HbA1c分层:≤6%(n=1087)、>6%至≤7%(n=2137)、>7%至≤8%(n=1657)、>8%(n=2846)。
  • 采用多因素logistic回归分析术前HbA1c与院内不良肢体事件、主要不良心血管事件及死亡的风险关联。

主要发现

  • 院内不良肢体事件356例(4.6%),主要不良心血管事件1314例(17.0%),院内死亡72例(0.9%)。
  • 调整临床和人口学变量后,HbA1c≥8%者较>6%至≤7%者不良肢体事件风险增加(OR 1.37;95%CI 1.01-1.86)。
  • HbA1c≥8%与心血管事件(OR 1.07;95%CI 0.81-1.43)或死亡(OR 1.57;95%CI 0.83-3.03)风险无显著关联。
  • HbA1c≤6%者三种结局风险均未显著升高。
  • 分层分析显示,HbA1c≥8%与不良肢体事件的关联仅存在于无严重肢体缺血患者(OR 1.82;95%CI 1.05-3.16)。

临床怎么用

  • 对拟行腹股沟下下肢旁路术的糖尿病患者,应识别术前HbA1c≥8%者,尤其无严重肢体缺血患者,并考虑优化血糖以降低院内不良肢体事件风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of preoperative glycemic control on the risk of adverse perioperative outcomes in diabetic patients undergoing lower extremity bypass (LEB) surgery is not well-understood. We determined whether higher preoperative hemoglobin A1c (HbA1c) levels are associated with an increased risk of major adverse limb events, major adverse cardiovascular events, and mortality in diabetic patients undergoing infrainguinal LEB. METHODS: A retrospective review of all infrainguinal LEB surgeries in the Vascular Quality Initiative registry from January 2012 to February 2017 was performed. Only surgeries performed on diabetic patients with complete demographic and clinical data, including HbA1c value at the time of LEB, were included for analysis (n = 7727). Entries were stratified according to the following HbA1c levels: 6 or less (n = 1087), greater than 6 to 7 or less (n = 2137), greater than 7 to 8 or less (n = 1657), and greater than 8 (n = 2846). Multivariate logistic regression was used to determine the association of preoperative HbA1c levels on the risk of in-hospital major adverse limb events (above ankle amputation, loss of primary graft patency), major adverse cardiovascular events (myocardial infarction, stroke, congestive heart failure, cardiac arrhythmia), and mortality. RESULTS: The number of surgeries complicated by adverse limb and cardiovascular events were 356 (4.6%) and 1314 (17.0%), respectively. There were 72 in-hospital deaths (0.9%). After adjustment for clinical and demographic variables, patients with high HbA1c values (≥8%) were at an increased risk of adverse limb events (odds ratio [OR], 1.37; 95% confidence interval [CI], 1.01-1.86) compared with those with a normal HbA1c (>6% to ≤7%). High HbA1c values were not associated with an increased risk of cardiovascular events (OR, 1.07; 95% CI, 0.81-1.43) or mortality (OR, 1.57; 95% CI, 0.83-3.03). Patients with low HbA1c values (≤6%) did not experience a significantly higher risk for any of the three outcomes. In a stratified analysis, the association of high HbA1c values with adverse limb events was only present in those presenting without critical limb ischemia (OR 1.82; 95% CI, 1.05-3.16). CONCLUSIONS: Poor preoperative glycemic control in diabetic individuals undergoing infrainguinal LEB, particularly in those without critical limb ischemia, is associated with an increased risk of in-hospital limb events. Further study should evaluate whether improved efforts to identify individuals with poorly controlled diabetes and subsequent interventions to better optimize glycemic control during the preoperative period improve limb outcomes after LEB.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Singh N, Zeng C, Lewinger JP, et al. Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative. J Vasc Surg. 2019. PMID: 30852042. doi:10.1016/j.jvs.2018.12.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。